Study of Hsp90 Inhibitor, STA-9090 for Relapsed or Refractory Small Cell Lung Cancer
Clinical trial NCT01173523 · COMPLETED
Trial details
- NCT number
- NCT01173523
- Sponsor
- David M. Jackman, MD
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2010-07-28
- Primary completion
- 2013-06-07
- Enrollment
- 25
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.